Respiratory Pathogen Testing Kits Market Research, 2031
The global respiratory pathogen testing kits market was valued at $2.2 billion in 2021, and is projected to reach $3.7 billion by 2031, growing at a CAGR of 5.5% from 2022 to 2031. The respiratory tract infections are the most common diseases affecting humans. It can be associated with both self-limiting upper respiratory tract infections such as the common cold and more severe lower respiratory tract infections (LRTIs) such as bronchitis, bronchiolitis, pneumonitis, and pneumonia.
The lower respiratory tract infections (LRTIs) are a major cause of hospitalization, morbidity, and mortality in infants and the elderly and are associated with significant disease burden. According to the data by National Institute of Health, the number of viral respiratory episodes per year in developed countries has been estimated between 6 and 10 in children before school age versus 3 to 5 in those after this age and acute respiratory infection remains the cause of 30% to 40% of hospital admissions in this category of patients. A wide range of pathogens are involved in acute respiratory infection, including bacteria and viruses. The identification of the causative agent(s) is often omitted or limited to a few pathogens easy to detect by rapid antigen direct tests such as influenza viruses and respiratory syncytial virus (RSV) in respiratory specimens and Streptococcus pneumoniae & Legionella pneumophila in urine specimens.
“The respiratory pathogen testing kits market was slightly increased during the lockdown period owing to the rise in demand of respiratory pathogen testing kits. respiratory pathogen testing kit has helped the overall respiratory pathogen testing kits industry to grow significantly as demand for pathogen testing kits increased to improve diagnostic systems during COVID-19”
Historical Overview
The market was analyzed qualitatively and quantitatively from 2021-2031. The respiratory pathogen testing kits market grew at a CAGR of around 5.5% during 2022-2031. Most of the growth during this period was derived from the Asia-Pacific owing to the improving health awareness, rising disposable incomes, as well as the well-established presence of domestic companies in the region.
Market Dynamics
Growth & innovations in the diagnostic and biotech industry for the manufacturing of respiratory pathogen testing kits owing to massive pool of respiratory infections incidences that creates a Respiratory Pathogen Testing Kits Market Opportunity. Rise in launch of new testing kits made up of advanced technology by various key players across the globe is set to affect the market growth positively. For instance, in September 2020, LabCorp announced the launch of the first testing method to simultaneously detect COVID-19, influenza A / B, and respiratory syncytial virus (RSV). The single-panel test, which detects multiple types of infections, can help doctors diagnose patients and make decisions about treatment options. The growth of the respiratory pathogen testing kits market is expected to be driven by high potential in untapped, emerging markets, due to availability of improved healthcare infrastructure, increase in unmet healthcare needs, rise in prevalence of chronic diseases, and surge in demand for respiratory pathogen testing kits.
Furthermore, the healthcare industry in emerging economies is developing at a significant rate, owing to rise in demand for enhanced healthcare services, significant investments by government to improve healthcare infrastructure, and development of the medical tourism industry in emerging countries. E-commerce (electronic commerce) has become a vital tool for small and large businesses globally, due to rise in preference of consumers for online shopping over traditional purchasing methods. This is attributed to further supports the growth of Respiratory Pathogen Testing Kits Market Size. The demand for respiratory pathogen testing kits is not only limited to developed countries but is also being witnessed in the developing countries, such as China, Brazil, and India, which fuel the growth of the Respiratory Pathogen Testing Kits Market Size. Factors such as rise in adoption of respiratory testing kits, and increase in awareness towards pathogen testing, further drive the growth of the market. Furthermore, rise in consumer awareness related to preventive healthcare and ease of accessibility boost the adoption of respiratory pathogen testing kits. Moreover, increase in promotional activities by manufacturers and growth in awareness for respiratory testing kits among the general population are expected to fuel their adoption in the near future.
Though the use of vegetarian concepts in the drug industry has propelled a changeover trend among the drug manufacturers from using animal gelatin capsules to vegetable capsules, there is still a long way for this paradigm shift to take total effect as the reimbursement concerns over the testing kits are creating an enormous downfall in the market growth. All it leads to is one major drawback for importers and distributors. Moreover, the unfavorable regulatory scenarios of the products used for testing is anticipated to hamper the Respiratory Pathogen Testing Kits Market Growth.
The COVID-19 pandemic affected the respiratory pathogen testing kits industry in a positive way, like various other diagnostics and biotechnology industries were affected. The COVID-19 has helped to increase the demand for pathogen testing technology to detect the molecular tests and for mapping COVID-19 antibody for Covid-19 infection. Increase in the demand of COVID-19 vaccines has increased the research and development activities during Covid-19. It is due to the increase in cases of COVID-19 each day globally. Various companies had adopted the product launch to check immune monitoring, diagnostics tests and vaccines development. For instance, in April 2020, JPT Peptide Technologies (JPT) has launched of ready-to-use peptide tools to study and profile the immune response towards SARS-CoV-2 infection. However, the major disturbance in the growth of pathogen testing technology applications was the disturbances in supply chain due to various industries shutdown their business due to the lockdown imposed, including instruments and consumables manufacturers. This was further impacted by various transport restrictions imposed globally to curb the spread of the pandemic.
The respiratory pathogen testing kits market is segmented into End User, Product Type and Application.
The global respiratory pathogen testing kits market is segmented based on product type, application, end user and region. On the basis of product type, the market is bifurcated into RT PCR kits, lateral flow test kits, ELISA kits and others. On the basis of application, the market is classified into influenza virus infection, respiratory syncytial virus infection and others. On the basis of end user, the market is classified into hospitals, diagnostic centers and others. Region wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
By Product Type
On the base of product type, the market is classified into RT PCR kits, lateral flow test kits, ELISA kits, and others. The lateral flow test kits segment dominated the global market in 2021, and is expected to remain dominant throughout the forecast period, owing to the increase in the adoption of RT PCR kits for various diagnostic procedures of chronic disease and the availability of respiratory pathogen testing kits in the market by various key players.
By Application
The respiratory pathogen testing kits market is segregated into influenza virus infection, respiratory syncytial virus infection, and others. The influenza virus infection segment dominated the global Respiratory Pathogen Testing Kits Market Share in 2021, and is anticipated to continue this trend during the Respiratory Pathogen Testing Kits Market Forecast period. This is attributed to increase in application of pathogen testing in diagnosis of chronic respiratory diseases. In addition, growth in prevalence of chronic disease.
By End User
The market is classified into hospitals, diagnostic centers and others. The hospitals segment held the largest Respiratory Pathogen Testing Kits Market Share in 2021, and is expected to remain dominant throughout the forecast period, owing to hospitals and diagnostic centers are the oldest and most conventional medium for using respiratory pathogen testing kits to diagnose the patients, and easy of the availability of these products at retail stores.
By Region
The respiratory pathogen testing kits market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. In 2021, North America was the dominant region and is expected to remain dominant throughout the forecast period, owing to high prevalence rate of respiratory diseases, increase in the number market players and surge in the testing facilities in the region. However, Asia-Pacific is expected to witness the highest CAGR during the analysis period, owing to the presence of high populace countries such as India and China, which in turn increases the prevalence rate of infectious diseases, and the increasing number of strategies and trends adopted by the market players.
The major players in the respiratory pathogen testing kits include Abbott Laboratories, Altona Diagnostics, Becton Dickinson and Company, bioMérieux Inc., Danaher Corporation (Cepheid), F. Hoffmann-La Roche Ltd., Mylab Discovery Solutions Pvt Ltd., Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific Inc. are provided in this report.
COMPETITION ANALYSIS
Competitive analysis and profiles of the major players in the respiratory pathogen testing kits, such as Abbott Laboratories, Altona Diagnostics, Becton Dickinson and Company, bioMérieuxInc., Danaher Corporation (Cepheid), F. Hoffmann-La Roche Ltd., Mylab Discovery Solutions Pvt Ltd., Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific Inc. are provided in this report. There are some important players in the market such as Abbott Laboratories, bioMérieuxInc., and Danaher Corporation (Cepheid.). Major players have adopted product launch, product approval, and acquisition as key developmental strategies to improve the product portfolio of the respiratory pathogen testing kits market.
Some Examples Of Product Launches In The Market
In October 2020, New England Biolabs (US) launched the Luna Probe One-Step RT-qPCR 4X Mix with UDG.
In April 2020, JPT Peptide Technologies (JPT) launched of ready-to-use peptide tools to study and profile the immune response toward SARS-CoV-2 infection.
Further, in May 2020, The UC Irvine Vaccine R&D Center has developed a way to test COVID-19 immunity against 34 coronavirus antigens or 33 antigens.
In November 2020, Altona Diagnostics announced the launch of AltoStar Influenza Screen & Type RT-PCR Kit 1.5 enables the fast and reliable detection and differentiation of the known subtypes and strains of globally spread influenza viruses.
In February 2020, Altona Diagnostics GmbH, announced the launch of the RealStar SARS-CoV-2 RT-PCR Kit 1.0. for the detection of SARS-CoV-2 (previously 2019-nCoV) which is the causative agent of coronavirus disease 2019 (COVID-19).
Acquisitions In The Market
In February 2021, Thermo Fisher Acquired Mesa Biotech to expand its Life Sciences Solutions business segment. Through this acquisition, the revenue of this segment is predicted to extend by approximately $200 million in 2021.
Product Approval
In May 2020, Altona Diagnostics received Agência Nacional de Vigilância Sanitária (ANVISA) approval for RealStar SARS-CoV-2 RT-PCR Kit 1.0.
In April 2020, Altona Diagnostics receives Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for RealStar SARS-CoV-2 RT-PCR Kit U.S.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the respiratory pathogen testing kits market analysis from 2021 to 2031 to identify the prevailing respiratory pathogen testing kits market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the respiratory pathogen testing kits market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global respiratory pathogen testing kits market trends, key players, market segments, application areas, and market growth strategies.
Respiratory Pathogen Testing Kits Market Report Highlights
| Aspects | Details |
 Market Size By 2031 | USD 3.7 billion |
 Growth Rate | CAGR of 5.5% |
 Forecast period | 2021 - 2031 |
 Report Pages | 220 |
 By End User |
|
 By Product Type |
|
 By Application |
|
 By Region |
|
 Key Market Players | BIOMERIEUX SA, Siemens AG, Qiagen NV, Danaher Corporation, Abbott Laboratories, Altona Diagnostics, Thermo Fisher Scientific Inc., MYLAB DISCOVERY SOLUTIONS PRIVATE LIMITED, F Hoffman La Roche Ltd., Becton, Dickinson and Company |
Analyst Review
In accordance with several interviews conducted, the respiratory pathogen panel kit means an in vitro diagnostic test for the qualitative finding of the following microorganisms from respiratory samples and bacterial or viral cultures using Real-Time PCR method. The test kits only need a single sample to run tests for a wide variety of viruses and bacteria. It has a multiplexing reaction running in parallel in each tube to notice different targets with the help of four different dyes. Most respiratory infections cause mild to moderate symptoms. But the infections can be serious or even life-threatening to young children, the elderly, and people with weakened immune systems.
Asia-Pacific is expected to witness the highest CAGR during the analysis period, owing to the presence of high populace countries such as India and China, which in turn increases the prevalence rate of respiratory pathogen testing kits, increase in awareness about respiratory immunoassay diagnostics and increases in government expenditure on healthcare and other related trends adopted by the market players.
The total market value of the Respiratory Pathogen Testing Kits market is $2155.81 million in 2021.
The forecast period in the report is from 2022 to 2031.
North America is the largest regional market for Respiratory Pathogen Testing Kits
The market value of the Respiratory Pathogen Testing Kits market in 2022 was $2267.91 million.
The top companies that hold the market share in Respiratory Pathogen Testing Kits market are Abbott Laboratories, Altona Diagnostics, Becton Dickinson and Company, BioMÃrieux Inc., Danaher Corporation (Cepheid), F. Hoffmann-La Roche Ltd., Mylab Discovery Solutions Pvt Ltd., Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific Inc.
The base year for the report is 2021.
Yes, Respiratory Pathogen Testing Kits companies are profiled in the report.
The key trends in the Respiratory Pathogen Testing Kits market are by an advancements in the respiratory pathogen test kits and R&D in the Respiratory Pathogen Testing Kits treatment.
Loading Table Of Content...
